Citation Impact
Citing Papers
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Roles of tau protein in health and disease
2017
Microbiota in health and diseases
2022 Standout
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
2021
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
2021
Regulation and Functions of the ER-Associated Nrf1 Transcription Factor
2022 StandoutNobel
The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis
2017 Standout
ERK signalling: a master regulator of cell behaviour, life and fate
2020
New approaches and challenges to targeting the endocannabinoid system
2018
Psychedelics and Psychedelic-Assisted Psychotherapy
2020
Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease
2012
Gut microbiome and health: mechanistic insights
2022 Standout
Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling
2019
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Altered network hub connectivity after acute LSD administration
2018
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
2018
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
2017
The neural basis of psychedelic action
2022 Standout
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
2013 Standout
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
2017
Systematic Review of Gut Microbiota and Major Depression
2019
A review of antibiotics, depression, and the gut microbiome
2019
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Psychedelics and Other Psychoplastogens for Treating Mental Illness
2021
Cannabinoids and the expanded endocannabinoid system in neurological disorders
2019
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
2018
American Trip
2020 Standout
Models of psychedelic drug action: modulation of cortical-subcortical circuits
2021
Preparing for the Bursting of the Psychedelic Hype Bubble
2022 Standout
Works of Danilo De Gregorio being referenced
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
2021
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB 1R signaling and anxiety‐like behavior
2015
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice
2015
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
2018
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
2020
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice
2017
The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors
2016
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
2020
Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease
2010
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders
2018
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice
2014
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
2016
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
2021